Intersect ENT, Inc.
1555 Adams Drive
Menlo Park, California 94025
September 12, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | Intersect ENT, Inc. |
Registration Statement on Form S-3ASR
Filed May 13, 2022
No. 333-237805
Withdrawal of Registration Withdrawal Request Previously Made on Form RW
Ladies and Gentlemen:
Intersect ENT, Inc., a Delaware Corporation (the “Company”), hereby respectfully requests the withdrawal, with such withdrawal to be approved effective immediately, of the registration withdrawal request filed on behalf of the Company on May 13, 2022 on Form RW (accession number 0001140361-22-019003) (the “Form RW”) in respect of the above-referenced registration statement. The Company is withdrawing the Form RW pursuant to discussions with the Securities and Exchange Commission, and is filing post-effective amendment relating to the Form S-3ASR to remove from registration any securities registered but not sold under such registration statement.
If you have any questions regarding this letter, please contact Tara Fisher, Ropes & Gray LLP, at (617) 235-4824 or tara.fisher@ropesgray.com.
Very truly yours, | ||
INTERSECT ENT, INC. | ||
By: | /s/ Christopher Cleary | |
Name: | Christopher Cleary | |
Title: | Senior VP, Corporate Development |